Molecular alterations in sporadic breast cancer
F Lerebours, R Lidereau - Critical reviews in oncology/hematology, 2002 - Elsevier
Breast cancer is a genetic disease. Like other human cancers, it is thought to occur as the
result of progressive accumulation of genetic aberrations. These aberrations result in a …
result of progressive accumulation of genetic aberrations. These aberrations result in a …
[HTML][HTML] Novel strategies on personalized medicine for breast cancer treatment: an update
Breast cancer is the most common cancer type among women worldwide. With breast
cancer patients and survivors being reported to experience a repertoire of symptoms that are …
cancer patients and survivors being reported to experience a repertoire of symptoms that are …
[HTML][HTML] Targeted therapy and mechanisms of drug resistance in breast cancer
Simple Summary Internationally, in women, breast cancer (BC) is the most common cancer
type and is the leading cause of cancer-related death. There are two main histological …
type and is the leading cause of cancer-related death. There are two main histological …
Somatic variation and cancer: therapies lost in the mix
AV Biankin, TJ Hudson - Human genetics, 2011 - Springer
Cancer arises as a consequence of mutations in genomes of cancer cells, which over time
allow them to proliferate and spread to distant sites. Large-scale sequencing of cancer …
allow them to proliferate and spread to distant sites. Large-scale sequencing of cancer …
Distinct gene mutation profiles among luminal-type and basal-type breast cancer cell lines
A Hollestelle, JHA Nagel, M Smid, S Lam… - Breast cancer research …, 2010 - Springer
Breast cancer has for long been recognized as a highly diverse tumor group, but the
underlying genetic basis has been elusive. Here, we report an extensive molecular …
underlying genetic basis has been elusive. Here, we report an extensive molecular …
Subtype and pathway specific responses to anticancer compounds in breast cancer
LM Heiser, A Sadanandam, WL Kuo… - Proceedings of the …, 2012 - National Acad Sciences
Breast cancers are comprised of molecularly distinct subtypes that may respond differently to
pathway-targeted therapies now under development. Collections of breast cancer cell lines …
pathway-targeted therapies now under development. Collections of breast cancer cell lines …
[HTML][HTML] Signaling network assessment of mutations and copy number variations predict breast cancer subtype-specific drug targets
N Zaman, L Li, ML Jaramillo, Z Sun, C Tibiche… - Cell reports, 2013 - cell.com
Individual cancer cells carry a bewildering number of distinct genomic alterations (eg, copy
number variations and mutations), making it a challenge to uncover genomic-driven …
number variations and mutations), making it a challenge to uncover genomic-driven …
Tumour heterogeneity of breast cancer: from morphology to personalised medicine
Breast cancer (BC) displays striking clinical, morphological, and behavioural diversity within
a single tumour and between tumours. Currently, mounting evidence indicates that the …
a single tumour and between tumours. Currently, mounting evidence indicates that the …
Current status of prognostic profiling in breast cancer
L Pusztai - The Oncologist, 2008 - academic.oup.com
Abstract Learning Objectives After completing this course, the reader will be able to: Assess
emerging data on the use of genetic groupings of breast cancer as predictive factors, and …
emerging data on the use of genetic groupings of breast cancer as predictive factors, and …
Through a glass darkly: advances in understanding breast cancer biology, 2000–2010
LA Carey - Clinical breast cancer, 2010 - Elsevier
Our understanding of breast cancer as a clinical and biologic entity has been gaining
granularity for several decades; in particular, the importance of hormone receptors and …
granularity for several decades; in particular, the importance of hormone receptors and …